Valuation: Sartorius AG

Market Cap 18B 20.09B 16.55B 15B 28.04B 1,908B 28.56B 197B 79.24B 1,004B 75.41B 73.81B 3,165B P/E 2026 *
73.6x
P/E 2027 * 57.7x
Enterprise Value 21.57B 24.09B 19.84B 17.98B 33.61B 2,287B 34.24B 237B 95B 1,203B 90.4B 88.48B 3,794B EV / Sales 2026 *
5.78x
EV / Sales 2027 * 5.18x
Free-Float
35.87%
Yield 2026 *
0.27%
Yield 2027 * 0.32%
1 day-2.76%
1 week+3.15%
1 month+11.17%
3 months+29.38%
6 months+31.16%
Current year+19.90%
1 week 220.5
Extreme 220.5
236
1 month 195.2
Extreme 195.2
236
Current year 158.2
Extreme 158.2
236
1 year 158.2
Extreme 158.2
236
3 years 131.4
Extreme 131.4
290
5 years 131.4
Extreme 131.4
552
10 years 65.02
Extreme 65.02
834
Manager TitleAgeSince
Chief Executive Officer 59 2025-06-29
Director of Finance/CFO 55 2024-03-31
Chief Operating Officer 70 2000-12-31
Director TitleAgeSince
Director/Board Member 62 2002-08-31
Chairman 69 2017-07-18
Director/Board Member 77 2011-11-28
Change 5-day change 1-year change 3-year change Capi.($)
-2.76%+3.15% - - 20.09B
-1.72%+3.44%+22.84%+56.71% 258B
-2.00%+0.75%+7.82%+20.94% 163B
-3.73%-4.48%-19.14%+64.75% 150B
-1.66%-8.12%-58.32%-17.99% 60.84B
-2.57%+3.30%+11.59%+44.40% 53.03B
-.--%+2.46%-11.69%-7.41% 53.31B
-3.47%+1.04%+19.48%+69.17% 49.3B
+0.84%-3.12%+7.47%+62.40% 50.67B
-3.61%+1.99%+32.36%+93.99% 45.46B
Average -2.07%-0.30%+1.38%+43.00% 98.16B
Weighted average by Cap. -2.12%+0.15%+4.02%+44.65%

Financials

2026 *2027 *
Net sales 3.73B 4.17B 3.43B 3.11B 5.81B 396B 5.92B 40.94B 16.43B 208B 15.64B 15.31B 656B 4.11B 4.59B 3.78B 3.42B 6.4B 435B 6.52B 45.05B 18.08B 229B 17.21B 16.84B 722B
Net income 259M 290M 239M 216M 404M 27.5B 412M 2.85B 1.14B 14.47B 1.09B 1.06B 45.63B 335M 374M 308M 279M 521M 35.47B 531M 3.67B 1.47B 18.66B 1.4B 1.37B 58.83B
Net Debt 3.58B 3.99B 3.29B 2.98B 5.57B 379B 5.68B 39.24B 15.75B 200B 14.99B 14.67B 629B 3.27B 3.65B 3.01B 2.73B 5.1B 347B 5.19B 35.89B 14.41B 182B 13.71B 13.42B 575B
Projected Income Statement - Annual - Sartorius AG
Logo Sartorius AG
Sartorius AG is a Germany-based supplier of pharmaceutical and laboratory equipment. It operates in two segments: bioprocess solutions and lab products and services. The bioprocess solutions segment offers integrated solutions for biopharmaceutical manufacture, such as filters for sterilization of biopharmaceutical media, single-use bags for cell cultivation and storage of biopharmaceuticals, membrane adsorbers for purification in bioprocesses, filter technology for clarification, among others. The lab Products and Services segment provides instruments, consumables, and services for laboratories, including laboratory balances, laboratory water systems for storage of purified water, electronic pipettes, filter systems for sample preparation, and membrane filter systems for sterility testing of parenteral.
Employees
14,273
Date Price Change Volume
26-10-30 €229.00 -2.76% 2,792
26-10-29 €235.50 +2.39% 5,504
26-10-28 €230.00 +1.32% 4,702
26-10-27 €227.00 +0.22% 6,293
26-10-26 €226.50 +2.03% 12,080
Trader
Investor
Global
Quality
ESG MSCI
AA
MarketScreener Ratings - Sartorius AG
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
19
Last Close Price
291.80EUR
Average target price
289.84EUR
Spread / Average Target
-0.67%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Sartorius AG